Hit Wegovy weight-loss drug on track for $4 billion in U.S. sales despite supply constraints, analyst says

The hit Wegovy weight-loss drug is on track for sales of over $4 billion this year in the U.S. alone, despite its manufacturer Novo Nordisk struggling to keep up with demand.